4.4 Review

Metformin and Aging: A Review

期刊

GERONTOLOGY
卷 65, 期 6, 页码 581-590

出版社

KARGER
DOI: 10.1159/000502257

关键词

Rejuvenation; Longevity; Health span; Metformin; Fisetin

向作者/读者索取更多资源

Metformin is sometimes proposed to be an anti-aging drug, based on preclinical experiments with lower-order organisms and numerous retrospective data on beneficial health outcomes for type 2 diabetics. Large prospective, placebo-controlled trials are planned, in pilot stage or running, to find a new use (or indication) for an aging population. As one of the metformin trials has frailty as its endpoint, similar to a trial with a plant-derived senolytic, the latter class of novel anti-aging drugs is briefly discussed. Concerns exist not only for vitamin B-12 and B-6 deficiencies, but also about whether there are adverse effects of metformin on individuals who try to remain healthy by maintaining cardiovascular fitness via exercise.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据